Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis — Suppressive effect of TA-383 on interleukin 6 production
- 31 May 1993
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (4) , 515-519
- https://doi.org/10.1016/0192-0561(93)90066-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Enhanced expression of interleukin 6 in rat and murine arthritis modelsInternational Journal of Immunopharmacology, 1993
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- IL-6 is produced by osteoblasts and induces bone resorption.The Journal of Immunology, 1990
- Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synoviumClinical Immunology and Immunopathology, 1989
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988
- Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodiesEuropean Journal of Immunology, 1988
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.The Journal of Experimental Medicine, 1988
- Induction of cyclo‐oxygenase by interleukin‐1 in rheumatoid synovial cellsFEBS Letters, 1987
- Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action.The Journal of Immunology, 1986
- Binding of (3H)prostaglandin E1 to putative receptors linked to adenylate cyclase of cultured cell clones.Journal of Biological Chemistry, 1976